A report on the outputs, outcome and impact generated by the projects funded in the various JPIAMR transnational research project and network calls under the Therapeutics priority topic has been published.
This report has been prepared using information provided by the coordinators of the research projects and networks in the mid-term and the final term progress reports. The aim is to disseminate information about the outputs and the outcomes of the funded projects and networks to highlight the promising results of the funded research. Some highlights from the report on the main achievements of the Therapeutics research projects and networks and the impact generated are:
- The JPIAMR discovery pipeline resulting from the funded research projects has a high level of diversity including direct acting molecules, potentiators or enablers, anti-virulence agents, repurposed agents, phage and nanobiotics.
- Six new candidates/leads have been identified and five patents have been filed.
- In addition to the peer-reviewed scientific articles in highly-recognised journals, the research projects and networks have also published white papers, roadmaps and position papers that can contribute to evidence-based policymaking.
Download the report: JPIAMR therapeutics discovery pipeline: Outputs, outcomes and impact of the funded projects and networks in the Therapeutics priority topic of the JPIAMR-SRIA (pdf 0,8 MB)
